In a mouse study, the team located key molecules that switch on stress pathways in preterm lung disorders, and also found that when parts of these pathways were blocked with a pain drug, lung damage was prevented or reversed.
The findings are published online ahead of print in the March issue of American Journal of Respiratory Cell and Molecular Biology.
Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in premature infants and does not have any specific treatment. The disorder affects about 97% of infants with birth weights below 1,250 grams, and can lead to repeated respiratory tract infections, as well as to emphysema and chronic obstructive pulmonary disease in adulthood.
A research team led by Vineet Bhandari, M.D., associate professor of pediatric neonatology and obstetrics, gynecology & reproductive sciences at Yale School of Medicine, theorized that if the molecules that cause these disorders can be blocked early on, they could essentially prevent lifelong lung problems.
Bhandari and his team studied the lung tissue of newborn mice. The team noted that when this lung tissue was exposed to hyperoxia —excess oxygen in tissues and organs that activates all components of the stress pathways in the newborn lung— there was a marked increase of cyclooxygenase 2 (Cox2) in the lung's stress pathways. This action resulted in BPD in mice. Once the team used a drug that inhibits Cox2, they were able to reverse BPD in mice.
"This is the first time hyperoxia has been comprehensively shown to be responsible for activating the stress pathway in developing lungs," said Bhandari. "Hyperoxia can induce interferon gamma and disrupt lung development, leading to BPD in mice. Once we used the Cox2 inhibitor Celecoxib, we were able to reverse the effects in the mouse BPD models. The drug, originally indicated to treat pain, protected the lungs from cell death, and was able to prevent destruction of and damage to the developing lung exposed to hyperoxia or excess interferon gamma in room air."
Bandari added that the findings suggest that Cox2 and or CHOP — a molecule important in the stress pathway — are potential new drug targets that can be inhibited to treat or prevent human BPD.
Bhandari said the next step is to conduct pre-clinical studies.
Other authors on the study include Rayman Choo-Wing; Mansoor A. Syed; Anantha Harijith, M.D.; Brianne Bowen; Gloria Pryhuber; M.D.; Cecilia Janér, M.D.; Sture Andersson, M.D.; and Robert J. Homer, M.D.
Citation: Am. J. Respir. Cell. Mol. Biol. doi:10.1165/rcmb.2012-0381OC (March 2013)
Karen N. Peart | Source: EurekAlert!
Further information: www.yale.edu
More articles from Life Sciences:
The secret of DNA methylation
19.06.2013 | Université de Genève
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer
19.06.2013 | Ohio State University Medical Center
- Biological fermentation process converts CO and CO2 into bioethanol and platform chemicals
- Process uses energy contained in steel plant off-gases
- Ten-year co-operation to develop and market integrated environmental solutions for the steel industry worldwide
Siemens Metals Technologies and LanzaTech have signed a ten-year co-operation agreement to develop and market integrated environmental solutions for the steel industry worldwide. The collaboration will utilize the ground-breaking fermentation technology developed by LanzaTech transforming carbon-rich off-gases generated by the steel industry into low carbon bioethanol and other platform chemicals. ...
Novel application of 3D printing could enable the development of miniaturized medical implants, compact electronics, tiny robots, and more
3D printing can now be used to print lithium-ion microbatteries the size of a grain of sand. The printed microbatteries could supply electricity to tiny devices in fields from medicine to communications, including many that have lingered on lab benches for lack of a battery small enough to fit the ...
... two engines aircraft project “Elektro E6”.
The countdown has been started for opening the gates again for the worldwide leading aviation and space event in Le Bourget, Paris from June 17th - 23rd, 2013.
EADCO & PC-Aero will present at the Paris Air Show in Hall H4 booth F-7 their new future aircraft and innovative project: ...
Siemens scientists have developed new kinds of ceramics in which they can embed transformers.
The new development allows power supply transformers to be reduced to one fifth of their current size so that the normally separate switched-mode power supply units of light-emitting diodes can be integrated into the module's heat sink.
The new technology was developed in cooperation with industrial and research partners who ...
Cheaper clean-energy technologies could be made possible thanks to a new discovery.
Led by Raymond Schaak, a professor of chemistry at Penn State University, research team members have found that an important chemical reaction that generates hydrogen from water is effectively triggered -- or catalyzed -- by a nanoparticle composed of nickel and phosphorus, two inexpensive elements that are abundant on Earth. ...
19.06.2013 | Life Sciences
19.06.2013 | Agricultural and Forestry Science
19.06.2013 | Studies and Analyses
14.06.2013 | Event News
13.06.2013 | Event News
10.06.2013 | Event News